top of page
From Worms to Workstreams: How Ora Biomedical Is Scaling AI Driven Longevity Discovery
Mini StartUp Review & Example for Fractional BD Opportunity By Henning Mann, PhD | HM.BioConsulting 3–5 minute read Download the File “Longevity research is evolving. AI and automation are accelerating drug discovery. In this space Ora Biomedical is one to watch.” Background: Aging as a Modifiable Endpoint Aging is the single greatest risk factor for most chronic diseases, yet for decades, drug discovery pipelines have focused on treating symptoms rather than addressing upstr
Henning Mann
11 hours ago3 min read
bottom of page